Timeframes' monitoringTimeframes for issuance of approvals are among the most important factors impacting sponsors’ decisions to conduct clinical trials in a country. The key objective of ACTO is to promote optimization of regulatory authorities' work and to speed up the process of granting approvals. To realize this objective ACTO monitors timeframes and working patterns of the regulatory system. This helps to identify problems and to develop appropriate solutions. 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007Timeframes' monitoring (2021 year) March 2022 Timeframes' monitoring (2020 year) February 2021 Timeframes' monitoring (2019 year) February 2020 Timeframes' monitoring (2018 year) February 2019 Timeframes' monitoring (2017 year) February 2018 Timeframes' monitoring (2016 year) March 2017 Timeframes' monitoring (2015 year) April 2016 Timeframes' monitoring (2014 year) April 2016 Timeframes' monitoring (2013 year) February 2014 Timeframes' monitoring (2012 year) April 2013 Timeframes' monitoring (2nd half of 2012 year) April 2013 Timeframes' monitoring (1st half of 2012 year) August 2012 Timeframes' monitoring 2011 (Jan-Dec) February 2012 Timeframes' monitoring 2011 (Jan-Jun) August 2011 Timeframes' monitoring 2010 (Sep-Dec) February 2011 Timeframes' monitoring 2010 (Jan-Aug) September 2010 Timelines' monitoring 2009 January 2010 Statistics about timelines 2009 January 2010 Timelines' monitoring 2008 January 2009 Statistics about timelines 2008 January 2009 Timelines' monitoring 2007 January 2008 |
 |
 |
New Articles 
Section "News":
Section "News":
The annual General Meeting of ACTO approved 2023 Report on Activities and the Board members for 2024
Section "News":
Section "News":
pdf, 888 Kb
xls, 416 Kb